LicianPro

Seer, Inc. ·

SEER 8-K 2026-11-10

Seer, Inc. (SEER) 8-K dated 2026-11-10 — accession 0001193125-26-455529.

Seer, Inc. (SEER) is a biotechnology company listed on NASDAQ.

SEER: Seer Reports Third Quarter 2026 Financial Results and Updates Full Year…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported SEER revenue for 2025-12-31 was $16.6M. Net income was -$73.6M. Revenue was up 17.0% from 2024-12-31 to 2025-12-31. SEER currently screens at market cap $94.6M.

Not investment advice. The SEER SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

Guidance
Full Year 2026 Revenue Guidance

Why it matters

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr